Construction of curcumin-loaded micelles and evaluation of the anti-tumor effect based on angiogenesis
Rui Liu, Zhongyan Liu, Xueli Guo, Dereje Kebebe, Jiaxin Pi, Pan Guo
Construction of curcumin-loaded micelles and evaluation of the anti-tumor effect based on angiogenesis
Objective: Inhibition of tumor angiogenesis has become a new targeted tumor therapy. In this study, we established a micellar carrier with a tumor neovascularization-targeting effect modified by the neovascularization-targeting peptide NGR.
Methods: The targeted polymer poly(ethylene glycol)-b-poly(lactide-co-glycolide) (PEG-PLGA) modified with Asn-Gly-Arg (NGR) peptide was prepared and characterized by 1H nuclear magnetic resonance and Fourier-transform infrared spectrometry. NGR-PEG-PLGA was used to construct curcumin (Cur)-loaded micelles by the solvent evaporation method. The physicochemical properties of the micelles were also investigated. Additionally, we evaluated the antitumor efficacy of the polymer micelles (PM) using in vitro cytology experiments and in vivo animal studies.
Results: The particle size of Cur-NGR-PM was 139.70β±β2.51 nm, and the drug-loading capacity was 14.37β±β0.06%. In vitro cytological evaluation showed that NGR-modified micelles showed higher cellular uptake through receptor-mediated endocytosis pathways than did unmodified micelles, leading to the apoptosis of tumor cells. Then, in vivo antitumor experiments showed that the modified micelles significantly inhibited tumor growth and were safe.
Conclusions: NGR-modified micelles significantly optimized the therapeutic efficacy of Cur. This strategy offers a viable avenue for cancer treatment.
Antitumor therapy / Curcumin (Cur) / Micelles / NGR / Tumor angiogenesis
[[1]] |
Mahtabifard A, Merritt RE, Yamada RE, et al.In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies. J Thorac Cardiovasc Surg. 2003;126(1):28-38.
|
[[2]] |
Shim JS, Kim JH, Cho HY, et al.Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chem Biol. 2003;10(8):695-704.
|
[[3]] |
Su L, Cao J, Jia Y, et al.Development of synthetic aminopeptidase N/CD13 inhibitors to overcome cancer metastasis and angiogenesis. ACS Med Chem Lett. 2012;3(12):959-964.
|
[[4]] |
Morgan R, Endres J, Behbahani-Nejad N, et al.Expression and function of aminopeptidase N/CD13 produced by fibroblast-like synoviocytes in rheumatoid arthritis: role of CD13 in chemotaxis of cytokine-activated T cells independent of enzymatic activity. Arthritis Rheumatol. 2015;67(1):74-85.
|
[[5]] |
Licona-Limon I, Garay-Canales CA, Munoz-Paleta O, et al.CD13 mediates phagocytosis in human monocytic cells. J Leukoc Biol. 2015;98(1):85-98.
|
[[6]] |
Liang W, Gao B, Xu G, et al.Possible contribution of aminopeptidase N (APN/CD13) to migration and invasion of human osteosarcoma cell lines. Int J Oncol. 2014;45(6):2475-2485.
|
[[7]] |
Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, et al.Curcumin and health. Molecules. 2016;21(3):264.
|
[[8]] |
Shanmugam MK, Rane G, Kanchi MM, et al.The multifaceted role of curcumin in cancer prevention and treatment. Molecules. 2015;20(2):2728-2769.
|
[[9]] |
Tomeh MA, Hadianamrei R, Zhao X.A Review of curcumin and its derivatives as anticancer agents. Int J Mol Sci. 2019;20(5):1033.
|
[[10]] |
Wang M, Jiang S, Zhou L, et al.Potential mechanisms of action of curcumin for cancer prevention: focus on cellular signaling pathways and miRNAs. Int J Biol Sci. 2019;15(6):1200-1214.
|
[[11]] |
Wang J, Wang C, Bu G.Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. Exp Ther Med. 2018;15(4):3650-3658.
|
[[12]] |
Pan Z, Zhuang J, Ji C, et al.Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression. Oncol Lett. 2018;15(4):4821-4826.
|
[[13]] |
Lu Y, Wang J, Liu L, et al.Curcumin increases the sensitivity of paclitaxel-resistant NSCLC cells to paclitaxel through microRNA-30c-mediated MTA1 reduction. Tumour Biol. 2017;39(4):1010428317698353.
|
[[14]] |
Menon VP, Sudheer AR.Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105-125.
|
[[15]] |
Kumar S, Fayaz F, Pottoo FH, et al.Nanophytomedicine based novel therapeutic strategies in liver cancer. Curr Top Med Chem. 2020;20(22):1999-2024.
|
[[16]] |
Pachauri M, Gupta ED, Ghosh PC.Piperine loaded PEG-PLGA nanoparticles: preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy. J Drug Delivery Sci Technol. 2015;29:269-282.
|
[[17]] |
Yang Y, Zhang J, Zou H, et al.Synthesis and evaluation of (68)Ga-labeled dimeric cNGR peptide for PET imaging of CD13 expression with ovarian cancer xenograft. J Cancer. 2021;12(1):244-252.
|
[[18]] |
Liu C, Qi W, Teng Z, et al.NGR-modified PEG-PLGA micelles containing Shikonin enhance targeting of dendritic cells for therapy of allergic rhinitis. Int Immunopharmacol. 2022;107:108649.
|
[[19]] |
Wang X, Wang Y, Chen X, et al.NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells. J Control Release. 2009;139(1):56-62.
|
[[20]] |
Zhao BJ, Ke XY, Huang Y, et al.The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats. J Drug Target. 2011;19(5):382-390.
|
[[21]] |
Jiao Z, Liu N, Chen Z.Selection suitable solvents to prepare paclitaxel-loaded micelles by solvent evaporation method. Pharm Dev Technol. 2012;17(2):164-169.
|
[[22]] |
Perumal S, Atchudan R, Lee W.A review of polymeric micelles and their applications. Polymers. 2022;14(12):2510.
|
[[23]] |
Lv Y, He H, Qi J, et al.Visual validation of the measurement of entrapment efficiency of drug nanocarriers. Int J Pharm. 2018;547(1-2):395-403.
|
[[24]] |
Xie X, Tao Q, Zou Y, et al.PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem. 2011;59(17):9280-9289.
|
[[25]] |
Qiao JB, Fan QQ, Xing L, et al.Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis. J Control Release. 2018;283:113-125.
|
[[26]] |
Qi X, Gao C, Yin C, et al.Development of quercetin-loaded PVCL-PVA-PEG micelles and application in inhibiting tumor angiogenesis through the PI3K/Akt/VEGF pathway. Toxicol Appl Pharmacol. 2022;437:115889.
|
[[27]] |
Song Z, Feng R, Sun M, et al.Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J Colloid Interface Sci. 2011;354(1):116-123.
|
[[28]] |
Gu Z, Chang M, Fan Y, et al.NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel. Colloids Surf B. 2017;160:395-405.
|
[[29]] |
Zhang K, Tang X, Zhang J, et al.PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications. J Control Release. 2014;183:77-86.
|
[[30]] |
Agrawal Y, Petkar KC, Sawant KK.Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 2010;401(1-2):93-102.
|
[[31]] |
Gao F, Chen Z, Zhou L, et al.Preparation, characterization and in vitro study of bellidifolin nano-micelles. RSC Adv. 2022;12(34):21982-21989.
|
[[32]] |
Ashour AA, El-Kamel AH, Mehanna RA, et al.Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis. Drug Deliv. 2022;29(1):3270-3280.
|
[[33]] |
Ding Y, Cui W, Sun D, et al.In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors. Drug Des Devel Ther. 2017;11:3105-3117.
|
[[34]] |
Zhou Z, Li L, Yang Y, et al.Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles. Biomaterials. 2014;35(24):6622-6635.
|
[[35]] |
Yuan R, Tao X, Liang S, et al.Protective effect of acidic polysaccharide from Schisandra chinensis on acute ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress. Biomed Pharmacother. 2018;99:537-542.
|
[[36]] |
Chen W, Luo Y, Liu L, et al.Cryptotanshinone inhibits cancer cell proliferation by suppressing mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation. Cancer Prev Res (Phila). 2010;3(8):1015-1025.
|
[[37]] |
Zou M, Zhang L, Xie Y, et al.NGR-based strategies for targeting delivery of chemotherapeutics to tumor vasculature. Anticancer Agents Med Chem. 2012;12(3):239-246.
|
[[38]] |
Saiki I, Fujii H, Yoneda J, et al.Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer. 1993;22(1):137-143.
|
/
〈 | 〉 |